Page last updated: 2024-09-05

cilengitide and Laryngeal Neoplasms

cilengitide has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kan, X; Liu, M; Liu, Y; Lu, JG; Wang, JT1

Other Studies

1 other study(ies) available for cilengitide and Laryngeal Neoplasms

ArticleYear
Cilengitide, a small molecule antagonist, targeted to integrin αν inhibits proliferation and induces apoptosis of laryngeal cancer cells in vitro.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2014, Volume: 271, Issue:8

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Integrin alphaV; Laryngeal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Snake Venoms

2014